Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing drugs safely.

John N van den Anker1

  • 1George Washington University School of Medicine and Health Sciences, 111 Michigan Avenue NW, Washington, DC 20010, United States. jvandena@cnmc.org

Seminars in Fetal & Neonatal Medicine
|February 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical cannabis utilization in children - a study based on a nationwide cohort.

Frontiers in pharmacology·2025
Same author

Effect of Alzheimer's disease medications on neurocognitive outcomes in children and adolescents with autism spectrum disorder and low IQ: a scoping review.

Translational psychiatry·2025
Same author

Caffeine in Preterm Infants and its Effect on Neonatal Sleep: A Systematic Review.

Journal of clinical pharmacology·2025
Same author

A Novel Maturation Equation for Hepatic Clearance Across Preterm, Term Neonates, Children, and Adults: Application to Paracetamol and Its Metabolite.

Journal of clinical pharmacology·2025
Same author

Physiologically Based and Population Pharmacokinetic Modeling of Midazolam in Children With Obesity Using Real-World Data.

Clinical and translational science·2025
Same author

Use of Tetracyclines During the Different Stages of Pregnancy.

JAMA network open·2024
Same journal

Strategies for prevention of intraventricular hemorrhage in the neonatal intensive care unit.

Seminars in fetal & neonatal medicine·2026
Same journal

Introduction.

Seminars in fetal & neonatal medicine·2026
Same journal

Introduction.

Seminars in fetal & neonatal medicine·2026
Same journal

Should inhaled nitric oxide be used for respiratory failure in preterm infants?

Seminars in fetal & neonatal medicine·2026
Same journal

Inhaled nitric oxide in premature infants for respiratory failure: Discussion and consensus.

Seminars in fetal & neonatal medicine·2026
Same journal

Critical thinking in red blood cell transfusion decisions: Donor, product, recipient, and outcomes.

Seminars in fetal & neonatal medicine·2026
See all related articles

Newborn infants face higher risks of adverse drug reactions. Legislation now aims to improve pediatric drug safety, necessitating blame-free adverse event reporting and electronic order entry to prevent medication errors.

Area of Science:

  • Neonatal pharmacology
  • Pediatric drug safety
  • Health policy

Background:

  • Newborn infants exhibit a higher susceptibility to adverse drug reactions compared to adults.
  • Historical drug legislation overlooked neonates until the Best Pharmaceuticals Act for Children in 2002.
  • Increased prescribing of licensed drugs for neonates is anticipated.

Purpose of the Study:

  • To highlight the critical need for improved drug safety in neonates.
  • To advocate for systems that support the analysis of drug-related errors.
  • To emphasize the importance of a blame-free environment for reporting adverse drug events.

Main Methods:

  • Review of existing data on neonatal adverse drug reactions.
  • Analysis of legislative history concerning pediatric drug safety.

Related Experiment Videos

  • Discussion of potential system improvements for medication safety.

    • Main Results:

    • Neonates are disproportionately affected by adverse drug events.
    • The Best Pharmaceuticals Act for Children marked a significant shift in pediatric drug safety policy.
    • Systemic improvements are crucial for enhancing medication safety in neonates.

    Conclusions:

    • Enhanced reporting of adverse drug events in a blame-free setting is essential for neonates.
    • Computerized physician order entry systems offer a promising solution to prevent medication errors.
    • Proactive measures are required to ensure the safe and effective use of medications in the neonatal population.